Literature DB >> 10684947

A rapid genetic screening system for identifying gene-specific suppression constructs for use in human cells.

G M Arndt1, M Patrikakis, D Atkins.   

Abstract

We describe a rapid cell-based genetic screen using fission yeast for identifying efficient gene suppression constructs (GSCs) from large libraries (10(5)) for any target sequence for use in human cells. In this system, target sequences are fused to the 5' end of the lacZ reporter gene and expressed in yeast. Random fragment expression libraries derived from the target sequence are screened in the fusion gene-expressing strain using the lacZ gene-encoded colony color phenotype. We demonstrate the utility of this screening assay by identifying a range of different GSCs for the fission yeast ura4 gene and human c-myc and Chk1 sequences, including rare efficient suppressors. GSCs specific for c-myc were shown to regulate expression of both a c-myc-lacZ fusion gene and the endogenous c-myc gene in human cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10684947      PMCID: PMC111056          DOI: 10.1093/nar/28.6.e15

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  24 in total

1.  Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25.

Authors:  Y Sanchez; C Wong; R S Thoma; R Richman; Z Wu; H Piwnica-Worms; S J Elledge
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

2.  Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays.

Authors:  H Zhu; J P Cong; G Mamtora; T Gingeras; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

3.  Discovery and analysis of inflammatory disease-related genes using cDNA microarrays.

Authors:  R A Heller; M Schena; A Chai; D Shalon; T Bedilion; J Gilmore; D E Woolley; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

4.  Selecting effective antisense reagents on combinatorial oligonucleotide arrays.

Authors:  N Milner; K U Mir; E M Southern
Journal:  Nat Biotechnol       Date:  1997-06       Impact factor: 54.908

Review 5.  Functional inactivation of genes by dominant negative mutations.

Authors:  I Herskowitz
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

6.  Theoretical design of antisense RNA structures substantially improves annealing kinetics and efficacy in human cells.

Authors:  V Patzel; G Sczakiel
Journal:  Nat Biotechnol       Date:  1998-01       Impact factor: 54.908

7.  Comparison of three 3' non-coding regions in Schizosaccharomyces pombe expression vectors: efficiencies of transcription termination and mRNA 3'-end formation.

Authors:  M Patrikakis; J G Izant; D Atkins
Journal:  Curr Genet       Date:  1996-07-31       Impact factor: 3.886

8.  Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.

Authors:  S A Williams; L Chang; J S Buzby; Y Suen; M S Cairo
Journal:  Leukemia       Date:  1996-12       Impact factor: 11.528

Review 9.  Life with 6000 genes.

Authors:  A Goffeau; B G Barrell; H Bussey; R W Davis; B Dujon; H Feldmann; F Galibert; J D Hoheisel; C Jacq; M Johnston; E J Louis; H W Mewes; Y Murakami; P Philippsen; H Tettelin; S G Oliver
Journal:  Science       Date:  1996-10-25       Impact factor: 47.728

Review 10.  Genome sequence of the nematode C. elegans: a platform for investigating biology.

Authors: 
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

View more
  2 in total

1.  Dominant genetic screen for cofactors that enhance antisense RNA-mediated gene silencing in fission yeast.

Authors:  Mitch Raponi; Greg M Arndt
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

2.  Double-stranded RNA-mediated gene silencing in fission yeast.

Authors:  Mitch Raponi; Greg M Arndt
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.